GILD vs OTTR · P/E 18, rev $7.80B vs P/E 11, rev $677.6M
Gilead Sciences Inc (GILD) versus Otter Tail Corporation (OTTR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Otter Tail Corporation (OTTR) is a conglomerates company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OTTR revenue for 2026-06-30 was $677.6M. Net income was $65.0M. Revenue was up 97.6% from 2026-03-31 to 2026-06-30. OTTR currently screens at market cap $3.34B and trailing P/E 11.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OTTR currently screens at market cap $3.34B and trailing P/E 11.4.
Not investment advice. Open the GILD and OTTR stock pages for the full models.
Not investment advice.